Clinical Trials for Challenging Cancer Cases at The Tisch Cancer ...

Developed to innovatively address treatment needs of patients at different disease stages, the trials are conducted in a regulatory-compliant ...

Cancer Clinical Trials for Patients | Icahn School of Medicine

The Tisch Cancer Institute (TCI) offers a wide range of clinical trials for patients with cancer. Our Clinical Research Support Unit (CRSU) offers Phase I, II, ...

Cancer Clinical Trials Office - Icahn School of Medicine at Mount Sinai

The Tisch Cancer Institute has a robust portfolio of research studies for patients with cancer. Find a Clinical Trial · For Patients.

We Find A Way | Mount Sinai Tisch Cancer Center experts treat ...

Mount Sinai Tisch Cancer Center experts treat complex cancer cases using the latest research and clinical trials. Helping patients through every challenge—from ...

Experimental Cancer Therapy Shows Success in More Than 70 ...

A new therapy that makes the immune system kill bone marrow cancer cells was successful in as many as 73 percent of patients in two clinical trials.

Optimizing care in early phase cancer trials: The role of palliative care

Advancements in cancer treatment have led to improved survival rates, with early phase clinical trials (EPCTs) serving as important initial steps in ...

Oncology clinical trial disruption during the COVID-19 pandemic

The institution-wide cohort included 4756 new patients enrolled to clinical trials from December 2019 to June 2021. A major decrease in the ...

Transforming NCI Cancer Clinical Trials

NCI is launching several initiatives to improve how its clinical trials operate, including those to increase participation among people of color and those who ...

Mentored Cancer Research Training Pipeline for Medical Students

The program's long-term aim is to advance the physician-scientist cancer research workforce through the development of a rigorous, structured, ...

Clinical Trials at The Tisch Cancer Institute: Moving the Field Forward

Patients, caregivers, faculty, and staff discuss their experiences with cancer clinical trials at The Tisch Cancer Institute at The Mount ...

A call to action to advance patient‐focused and decentralized ...

This commentary is a call to action for a concerted commitment and effort to transform clinical trials and enable people with cancer to ...

Preston Robert Tisch Brain Tumor Center | Duke Cancer Institute

The Preston Robert Tisch Brain Tumor Center is one of the first brain tumor research and clinical programs in the United States. T.

Checkpoint therapy in cancer treatment: progress, challenges, and ...

Another study on dostarlimab in 16 patients with dMMR stage II or III rectal cancer showed a 100% clinical response with no disease progression ...

Adult Cancer Clinical Trials That Fail to Complete: An Epidemic?

Among 7776 phase II–III adult cancer clinical trials initiated between 2005–2011, we found a seven-year cumulative incidence of failure to ...

Supportive Care Research - Preston Robert Tisch Brain Tumor Center

While traditional research focuses on clinical trials that directly treat cancer, we have designed supportive care research to support and improve patients' ...

Equitable Access to Clinical Trials: How Do We Achieve It?

Clinical trials are pivotal for testing novel drugs and establishing new standard-of-care treatments for patients with cancer. The advent of ...

Addressing the Social Needs of People with Cancer - NCI

“We look at our oncology patients as [the people they were] before they came to us,” said Jessica Kreitman, head of social work at the Dubin ...

Immunotherapy's Visible Promise Against Head and Neck Cancer

While treatment for head and neck cancer has its nuances, immunotherapy clinical trials can provide hope for patients, caregivers, and families.

Optimizing care in early phase cancer trials: The role of palliative ...

Patients who enroll on early phase clinical trials (EPCTs) usually have advanced cancer and heightened symptomatology, yet maintain a robust performance status ...

Experimental Cancer Therapy Shows Success in More | Newswise

A new therapy that makes the immune system kill bone marrow cancer cells was successful in as many as 73 percent of patients in two clinical ...